Erin Morgan

452 total citations
18 papers, 341 citations indexed

About

Erin Morgan is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Erin Morgan has authored 18 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Erin Morgan's work include Diabetes Treatment and Management (4 papers), Hormonal Regulation and Hypertension (4 papers) and Renin-Angiotensin System Studies (3 papers). Erin Morgan is often cited by papers focused on Diabetes Treatment and Management (4 papers), Hormonal Regulation and Hypertension (4 papers) and Renin-Angiotensin System Studies (3 papers). Erin Morgan collaborates with scholars based in United States, Netherlands and Germany. Erin Morgan's co-authors include Richard S. Geary, Sanjay Bhanot, Lynnetta M. Watts, Brenda F. Baker, Rohit Loomba, Shiangtung W. Jung, Shuting Xia, Michela Brambatti, Sotirios Tsimikas and Nguyen C. Pham and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Diabetes Care.

In The Last Decade

Erin Morgan

14 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erin Morgan United States 8 160 129 75 74 68 18 341
Amandine Bataille France 8 147 0.9× 70 0.5× 85 1.1× 51 0.7× 23 0.3× 8 353
Fangli Zhou China 10 142 0.9× 68 0.5× 60 0.8× 108 1.5× 38 0.6× 18 368
Dilare Adi China 12 135 0.8× 85 0.7× 99 1.3× 36 0.5× 115 1.7× 46 416
Chihiro Horimai Japan 7 155 1.0× 81 0.6× 41 0.5× 41 0.6× 61 0.9× 9 378
Emilio Ciccone United States 5 221 1.4× 56 0.4× 57 0.8× 61 0.8× 40 0.6× 5 462
Stela Z. Berisha United States 8 104 0.7× 86 0.7× 147 2.0× 65 0.9× 41 0.6× 11 342
Yusaku Shirai Japan 10 78 0.5× 111 0.9× 71 0.9× 246 3.3× 43 0.6× 16 406
Xuesi Wan China 14 174 1.1× 162 1.3× 120 1.6× 54 0.7× 39 0.6× 23 438
Shunkui Luo China 9 129 0.8× 72 0.6× 36 0.5× 144 1.9× 36 0.5× 15 325
Marcel G. M. Wolfs Netherlands 9 212 1.3× 77 0.6× 38 0.5× 120 1.6× 33 0.5× 9 530

Countries citing papers authored by Erin Morgan

Since Specialization
Citations

This map shows the geographic impact of Erin Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Morgan more than expected).

Fields of papers citing papers by Erin Morgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Morgan. The network helps show where Erin Morgan may publish in the future.

Co-authorship network of co-authors of Erin Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of Erin Morgan. A scholar is included among the top collaborators of Erin Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin Morgan. Erin Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Lidani, Kárita Cláudia Freitas, H A Ebrahimzadeh Mousavi, Robert Buscaglia, et al.. (2025). Genome-wide association study of angiotensinogen levels and key single nucleotide polymorphism associations with blood pressure. Journal of Hypertension. 43(9). 1500–1509.
2.
Lidani, Kárita Cláudia Freitas, Patrick J. Trainor, Robert Buscaglia, et al.. (2025). Circulating Levels of Angiotensinogen, Sex Hormones, and Hormone Therapy—The Multi‐Ethnic Study of Atherosclerosis (MESA). Journal of Clinical Hypertension. 27(6). e70083–e70083.
3.
Ji, Linong, Leili Gao, Guoliang Chen, et al.. (2024). ISIS 449884 Injection Add-On to Metformin in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase II Clinical Study. Diabetes Therapy. 15(10). 2183–2196. 1 indexed citations
4.
5.
Trainor, Patrick J., Michela Brambatti, Samantha M. Carlisle, et al.. (2023). Blood Levels of Angiotensinogen and Hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA). Journal of the American College of Cardiology. 81(13). 1248–1259. 7 indexed citations
6.
Morgan, Erin, Jason M. Duran, Tao Lin, et al.. (2023). Abstract 17395: Effect of ION904, an Antisense Inhibitor of Angiotensinogen Production: Results of Phase 1 and Phase 2 Pilot Studies. Circulation. 148(Suppl_1). 2 indexed citations
7.
Willmann, Stefan, Alexander Solms, Markus Jensen, et al.. (2021). PK/PD modeling of FXI antisense oligonucleotides to bridge the dose‐FXI activity relation from healthy volunteers to end‐stage renal disease patients. CPT Pharmacometrics & Systems Pharmacology. 10(8). 890–901. 36 indexed citations
8.
Morgan, Erin, Kevin Hu, Adam E. Mullick, et al.. (2021). EFFECT OF IONIS-AGT-LRX IN SUBJECTS WITH UNCONTROLLED HYPERTENSION ON 2-3 MEDICATIONS: RESULTS OF A PHASE 2 STUDY. Journal of the American College of Cardiology. 77(18). 1547–1547.
9.
Morgan, Erin, Kuolung Hu, Michela Brambatti, et al.. (2021). Antisense Inhibition of Angiotensinogen With IONIS-AGT-LRx. JACC Basic to Translational Science. 6(6). 485–496. 56 indexed citations
10.
Loomba, Rohit, Erin Morgan, Lynnetta M. Watts, et al.. (2020). Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial. ˜The œLancet. Gastroenterology & hepatology. 5(9). 829–838. 80 indexed citations
11.
12.
13.
Digenio, Andrés, Nguyen C. Pham, Lynnetta M. Watts, et al.. (2018). Antisense Inhibition of Protein Tyrosine Phosphatase 1B With IONIS-PTP-1BRx Improves Insulin Sensitivity and Reduces Weight in Overweight Patients With Type 2 Diabetes. Diabetes Care. 41(4). 807–814. 39 indexed citations
14.
Luu, Kenneth T., Erin Morgan, Sanjay Bhanot, et al.. (2017). Population pharmacokinetics and pharmacodynamics of IONIS-GCGRRx, an antisense oligonucleotide for type 2 diabetes mellitus: a red blood cell lifespan model. Journal of Pharmacokinetics and Pharmacodynamics. 44(3). 179–191. 11 indexed citations
15.
Dongen, Marloes G. J. van, Bart F. Geerts, Erin Morgan, et al.. (2014). First proof of pharmacology in humans of a novel glucagon receptor antisense drug. The Journal of Clinical Pharmacology. 55(3). 298–306. 37 indexed citations
16.
Geerts, Bart F., Sanjay Bhanot, Erin Morgan, et al.. (2014). Characterization of a Standardized Glucagon Challenge Test as a Pharmacodynamic Tool in Pharmacological Research. Hormone and Metabolic Research. 46(4). 269–273. 5 indexed citations
17.
Geller, David E., Patrick A. Flume, David C. Griffith, et al.. (2010). Pharmacokinetics (PK) of aerosol MP-376 (aeroquin; levofloxacin inhalation solution) in CF patients. Journal of Cystic Fibrosis. 9. S23–S23. 10 indexed citations
18.
Vaughan, J H, et al.. (1968). Role of gamma globulin complexes in rheumatoid arthritis.. PubMed. 81. 231–9. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amandine Bataille Breakdown of academic impact, for papers by Fangli Zhou Breakdown of academic impact, for papers by Dilare Adi Breakdown of academic impact, for papers by Chihiro Horimai Breakdown of academic impact, for papers by Emilio Ciccone Breakdown of academic impact, for papers by Stela Z. Berisha Breakdown of academic impact, for papers by Yusaku Shirai Breakdown of academic impact, for papers by Xuesi Wan Breakdown of academic impact, for papers by Shunkui Luo Breakdown of academic impact, for papers by Marcel G. M. Wolfs
Rankless by CCL
2026